Foradil Related Published Studies
Well-designed clinical trials related to Foradil (Formoterol Inhalation)
An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice. [2009.09.19]
Efficacy and tolerability of once-daily budesonide/formoterol pressurized metered-dose inhaler in adults and adolescents with asthma previously stable with twice-daily budesonide/ formoterol dosing. [2009.07]
Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol. [2009.05]
Effect of formoterol with or without budesonide in repeated low-dose allergen challenge. [2009.04]
Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD. A double-blind, randomised, non-inferiority, parallel-group, multicentre study. [2009.02.19]
Formoterol and tiotropium compared with tiotropium alone for treatment of COPD. [2009.02]
24-hour bronchodilator efficacy of single doses of indacaterol in subjects with COPD: comparison with placebo and formoterol. [2009.02]
Faster onset of action of formoterol versus salmeterol in patients with chronic obstructive pulmonary disease: a multicenter, randomized study. [2009.02]
Lung function and asthma control with beclomethasone and formoterol in a single inhaler. [2009.01]
Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial. [2009]
Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial. [2009]
Rational timing of combination therapy with tiotropium and formoterol in moderate and severe COPD. [2008.12]
Cost-effectiveness analysis of budesonide/formoterol maintenance and reliever therapy versus fixed combination treatments for asthma in Finland*. [2008.12]
Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler. [2008.11]
Arrhythmias in patients with chronic obstructive pulmonary disease (COPD): occurrence frequency and the effect of treatment with the inhaled long-acting beta2-agonists arformoterol and salmeterol. [2008.11]
Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study. [2008.11]
Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations. [2008.10]
Pharmacokinetics of budesonide and formoterol administered via a series of single-drug and combination inhalers: four open-label, randomized, crossover studies in healthy adults. [2008.10]
A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma. [2008.10]
Nebulized formoterol fumarate: Dose selection and pharmacokinetics. [2008.10]
Inflammatory and functional effects of increasing asthma treatment with formoterol or double dose budesonide. [2008.10]
Use of 6-min and 12-min walking test for assessing the efficacy of formoterol in COPD. [2008.10]
Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids. [2008.09]
Single-dose pharmacokinetics and safety pharmacodynamics of formoterol delivered by two different dry powder inhalers. [2008.09]
Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients. [2008.09]
Comparison of a Combination of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Moderate COPD. [2008.08]
A pharmacokinetic/pharmacodynamic study comparing arformoterol tartrate inhalation solution and racemic formoterol dry powder inhaler in subjects with chronic obstructive pulmonary disease. [2008.08]
Long-term safety of nebulized formoterol: results of a twelve-month open-label clinical trial. [2008.08]
Equivalence of a single saline nebulised dose of formoterol powder vs three doses of nebulised Albuterol every twenty minutes in acute asthma in children: a suitable cost effective approach for developing nations. [2008.07]
Budesomide/ formoterol as maintenance and reliever treatment compared to fixed dose combination strategies - a Canadian economic evaluation. [2008.06]
Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients. [2008.06]
[Immediate bronchodilator response to formoterol in poorly reversible chronic obstructive pulmonary disease] [2008.06]
Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids. [2008.05]
Budesonide/formoterol maintenance and reliever therapy: impact on airway inflammation in asthma. [2008.05]
Short term effect of a single dose of formoterol or tiotropium on the isolated nocturnal hypoxemia in stable COPD patients: a double blind randomized study. [2008.05]
Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: A placebo-controlled trial. [2008.04]
Efficacy of formoterol Turbuhaler in the emergency treatment of patients with obstructive airway diseases. [2008.04]
Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance. [2008.04]
Salmeterol vs. formoterol: a comparison of rapid bronchodilator effect in a randomized controlled trial. [2008.03]
The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma. [2008.03]
Bronchodilation of formoterol administered with budesonide: Device and formulation effects. [2008.03]
Effect of nebulized arformoterol on airway function in COPD: results from two randomized trials. [2008.02]
Efficacy and safety of formoterol fumarate delivered by nebulization to COPD patients. [2008.02]
Efficacy and safety of formoterol delivered through the Novolizer, a novel dry powder inhaler (DPI) compared with a standard DPI in patients with moderate to severe asthma. [2008]
Efficacy and safety of a new pressurised metered-dose inhaler formulation of budesonide/formoterol in children with asthma: a superiority and therapeutic equivalence study. [2008]
Once versus twice daily formoterol via Novolizer for patients with moderate to severe COPD--a double-blind, randomised, controlled trial. [2008]
Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease : results of a 6-month randomized clinical trial. [2008]
Tolerability of high cumulative doses of the HFA modulite beclomethasone dipropionate/formoterol combination inhaler in asthmatic patients. [2008]
Effects of formoterol on endurance performance in athletes at an ambient temperature of -20 degrees C. [2007.12]
Cardiac safety profile of nebulized formoterol in adults with COPD: a 12-week, multicenter, randomized, double- blind, double-dummy, placebo- and active-controlled trial. [2007.10]
Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy. [2007.10]
Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma. [2007.10]
Effects of formoterol on exercise tolerance in severely disabled patients with COPD. [2007.10]
Lung deposition and efficacy of inhaled formoterol in patients with moderate to severe COPD. [2007.09]
Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction. [2007.09]
Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma. [2007.08]
Formoterol, montelukast, and budesonide in asthmatic children: effect on lung function and exhaled nitric oxide. [2007.08]
Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life. [2007.07.04]
Canadian economic evaluation of budesonide-formoterol as maintenance and reliever treatment in patients with moderate to severe asthma. [2007.07]
Effects of topical formoterol alone and in combination with budesonide in a pollen season model of allergic rhinitis. [2007.06]
The additive effect of theophylline on a combination of formoterol and tiotropium in stable COPD: a pilot study. [2007.05]
Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma. [2007.05]
Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. [2007.05]
Nebulized arformoterol in patients with COPD: A 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial. [2007.02]
The effects of inhaled budesonide and formoterol in combination and alone when given directly after allergen challenge. [2007.02]
Cardiac safety of formoterol 12mug twice daily in patients with chronic obstructive pulmonary disease. [2007]
Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study. [2006.12.04]
Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma. [2006.12]
The effect of formoterol inhalation on endurance performance in hypobaric conditions. [2006.12]
Effect of formoterol, tiotropium, and their combination in patients with acute exacerbation of chronic obstructive pulmonary disease: A pilot study. [2006.11]
Formoterol as needed with or without budesonide in patients with intermittent asthma and raised NO levels in exhaled air: A SOMA study. [2006.10]
Effect of formoterol fumarate treatment on exercise-induced bronchoconstriction in children. [2006.09]
Budesonide/formoterol improves lung function compared with budesonide alone in children with asthma. [2006.09]
Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. [2006.08.26]
Comparison of the acute effect of tiotropium versus a combination therapy with single inhaler budesonide/formoterol on the degree of resting pulmonary hyperinflation. [2006.07]
Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study. [2006.05]
Acute relief of exercise-induced bronchoconstriction by inhaled formoterol in children with persistent asthma. [2006.05]
Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma. [2006.05]
Inhaled formoterol versus ipratropium bromide in chronic obstructive pulmonary disease. [2006.04]
Formoterol Turbuhaler as reliever medication in patients with acute asthma. [2006.04]
Safety and tolerability of high-dose formoterol (via Aerolizer) and salbutamol in patients with chronic obstructive pulmonary disease. [2006.04]
Cost-effectiveness analysis of budesonide/formoterol compared with fluticasone in moderate-persistent asthma. [2006.04]
Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD. [2006.03]
Improved lung function and symptom control with formoterol on demand in asthma. [2006.03]
Adjustable maintenance dosing with budesonide/formoterol or budesonide: double-blind study. [2006.03]
Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. [2006.02]
Effect of formoterol/budesonide combination on arterial blood gases in patients with acute exacerbation of COPD. [2006.02]
Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol. [2006.01.24]
Formoterol, 24 {micro}g bid, and Serious Asthma Exacerbations: Similar Rates Compared With Formoterol, 12 {micro}g bid, With and Without Extra Doses Taken on Demand, and Placebo. [2006.01]
The 24 h duration of bronchodilator action of the budesonide/formoterol combination inhaler. [2006.01]
Is there any difference between effects of ipratropium bromide and formoterol on exercise capacity in moderate COPD patients? [2006]
Formoterol induces tolerance to the bronchodilating effect of Salbutamol following methacholine-provocation test in asthmatic children. [2006]
Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma. [2006]
Onset and duration of action of formoterol and tiotropium in patients with moderate to severe COPD. [2006]
Clinically equivalent bronchodilatation achieved with formoterol delivered via Easyhaler and Aerolizer. [2006]
Safety of formoterol after cumulative dosing via Easyhaler and Aerolizer. [2005.12]
Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary disease. [2005.12]
Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? [2005.11]
Formoterol attenuates neutrophilic airway inflammation in asthma. [2005.10]
Formoterol induces tolerance to the bronchodilating effect of Salbutamol following methacholine-provocation test in asthmatic children. [2005.09.15]
Bronchoprotection with formoterol via dry powder and metered-dose inhalers in patients with asthma. [2005.09]
|
